Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts

Abstract Background Platelet aggregation and advanced glycation end products (AGEs) and oxidative stress are known as key factors for the development of cardiovascular diseases and diabetic complications. In this context, fruit and vegetable consumption, good sources of antioxidant compounds have be...

Full description

Bibliographic Details
Main Authors: Zahra Amri, Ikram Ben Amor, Amira Zarrouk, Raja Chaaba, Jalel Gargouri, Mohamed Hammami, Sonia Hammami
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:https://doi.org/10.1186/s12906-022-03824-6
_version_ 1797973757795500032
author Zahra Amri
Ikram Ben Amor
Amira Zarrouk
Raja Chaaba
Jalel Gargouri
Mohamed Hammami
Sonia Hammami
author_facet Zahra Amri
Ikram Ben Amor
Amira Zarrouk
Raja Chaaba
Jalel Gargouri
Mohamed Hammami
Sonia Hammami
author_sort Zahra Amri
collection DOAJ
description Abstract Background Platelet aggregation and advanced glycation end products (AGEs) and oxidative stress are known as key factors for the development of cardiovascular diseases and diabetic complications. In this context, fruit and vegetable consumption, good sources of antioxidant compounds have been largely reported as an effective way of preventing human against these diseases. The current study focuses on the evaluation of antioxidant, antiplatelet and anti-glycation activities of pomegranate (Punica granatum L.) flowers (PF), leaves (PL), peel (PP) juice (PJ) and seeds oil (PSO). Methods Antioxidant activities was measured against ABTS radical and lipid peroxidation. Antiglycation activity was determined using the formation of AGE fluorescence intensity in the BSA/ribose system. Antiplatelet activity was measured in platelet rich plasma (PRP) against adenosine diphosphate (ADP), Collagen and arachidonic acid (AA). Results PF extract displayed the highest antioxidant activity against ABTS and lipid peroxidation with IC50 values of 0.7 mg/mL and 0.63 mg/mL respectively. For anti-glycation activity, PP, PF and PL inhibited moderately the pentosidine-like AGEs formation compared to positive controls with AGE-IC50 value of 0.4 mg/mL. PJ and PSO haven’t any anti-AGE effect. All the extracts selectively inhibited platelet aggregation caused by one, two or three inducers in dose dependent manner. PF was the most potent inhibitor caused by all three inducers, with inhibitory effects ranging from 35.6 to 66.6%. PP and PJ exhibited antiplatelet effect against both ADP and collagen and PL and PSO only against AA. Conclusions These results suggest that some pomegranate extracts exert potential in vitro anti-glycative and antiplatelet activities.
first_indexed 2024-04-11T04:08:10Z
format Article
id doaj.art-166839b99d214dcab310a813eda77cb5
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-04-11T04:08:10Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-166839b99d214dcab310a813eda77cb52023-01-01T12:12:56ZengBMCBMC Complementary Medicine and Therapies2662-76712022-12-012211710.1186/s12906-022-03824-6Anti-glycation, antiplatelet and antioxidant effects of different pomegranate partsZahra Amri0Ikram Ben Amor1Amira Zarrouk2Raja Chaaba3Jalel Gargouri4Mohamed Hammami5Sonia Hammami6Biochemistry Laboratory, LR12ES05 “Nutrition- Functional Foods and vascular Health”, Faculty of Medicine, University of MonastirCentre Régional de Transfusion Sanguine de SfaxBiochemistry Laboratory, LR12ES05 “Nutrition- Functional Foods and vascular Health”, Faculty of Medicine, University of MonastirBiochemistry Laboratory, LR12ES05 “Nutrition- Functional Foods and vascular Health”, Faculty of Medicine, University of MonastirCentre Régional de Transfusion Sanguine de SfaxBiochemistry Laboratory, LR12ES05 “Nutrition- Functional Foods and vascular Health”, Faculty of Medicine, University of MonastirBiochemistry Laboratory, LR12ES05 “Nutrition- Functional Foods and vascular Health”, Faculty of Medicine, University of MonastirAbstract Background Platelet aggregation and advanced glycation end products (AGEs) and oxidative stress are known as key factors for the development of cardiovascular diseases and diabetic complications. In this context, fruit and vegetable consumption, good sources of antioxidant compounds have been largely reported as an effective way of preventing human against these diseases. The current study focuses on the evaluation of antioxidant, antiplatelet and anti-glycation activities of pomegranate (Punica granatum L.) flowers (PF), leaves (PL), peel (PP) juice (PJ) and seeds oil (PSO). Methods Antioxidant activities was measured against ABTS radical and lipid peroxidation. Antiglycation activity was determined using the formation of AGE fluorescence intensity in the BSA/ribose system. Antiplatelet activity was measured in platelet rich plasma (PRP) against adenosine diphosphate (ADP), Collagen and arachidonic acid (AA). Results PF extract displayed the highest antioxidant activity against ABTS and lipid peroxidation with IC50 values of 0.7 mg/mL and 0.63 mg/mL respectively. For anti-glycation activity, PP, PF and PL inhibited moderately the pentosidine-like AGEs formation compared to positive controls with AGE-IC50 value of 0.4 mg/mL. PJ and PSO haven’t any anti-AGE effect. All the extracts selectively inhibited platelet aggregation caused by one, two or three inducers in dose dependent manner. PF was the most potent inhibitor caused by all three inducers, with inhibitory effects ranging from 35.6 to 66.6%. PP and PJ exhibited antiplatelet effect against both ADP and collagen and PL and PSO only against AA. Conclusions These results suggest that some pomegranate extracts exert potential in vitro anti-glycative and antiplatelet activities.https://doi.org/10.1186/s12906-022-03824-6PomegranateAntiplatelet activityAdvanced glycation end-productsOxidative stressLipid peroxidation
spellingShingle Zahra Amri
Ikram Ben Amor
Amira Zarrouk
Raja Chaaba
Jalel Gargouri
Mohamed Hammami
Sonia Hammami
Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
BMC Complementary Medicine and Therapies
Pomegranate
Antiplatelet activity
Advanced glycation end-products
Oxidative stress
Lipid peroxidation
title Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
title_full Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
title_fullStr Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
title_full_unstemmed Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
title_short Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
title_sort anti glycation antiplatelet and antioxidant effects of different pomegranate parts
topic Pomegranate
Antiplatelet activity
Advanced glycation end-products
Oxidative stress
Lipid peroxidation
url https://doi.org/10.1186/s12906-022-03824-6
work_keys_str_mv AT zahraamri antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts
AT ikrambenamor antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts
AT amirazarrouk antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts
AT rajachaaba antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts
AT jalelgargouri antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts
AT mohamedhammami antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts
AT soniahammami antiglycationantiplateletandantioxidanteffectsofdifferentpomegranateparts